COMPARATIVE TRIAL OF TIBOLONE, CONJUGATED ESTROGEN THERAPY, RALOXIFENE AND ALENDRONATE ON THE OSTEOPOROSIS TRAETMENT OF POSTMENOPAUSAL WOMEN

Maturitas ◽  
2009 ◽  
Vol 63 ◽  
pp. S87
Author(s):  
S. Dimitrakopoulos ◽  
S. Koliantzaki ◽  
K. Sorras ◽  
A. Sidiropoulou ◽  
A. Saltamavros ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Estrogen Therapy ◽  
Comparative Trial ◽  
Conjugated Estrogen

P3.13.12 Fibrinolysis and carbohydrate metabolism (CHO) were not improved with estrogen therapy in postmenopausal women with type 2 diabetes mellitus (DM)

2000 ◽  
Vol 70 ◽  
pp. C121-C121
Author(s):  
C. Sztejnsznajd ◽  
M.E.R. Silva ◽  
N.R. Melo ◽  
A. Nussbacher ◽  
R.T. Fukui ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Carbohydrate Metabolism ◽  
Postmenopausal Women ◽  
Estrogen Therapy

Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women

2009 ◽  
Vol 16 (5) ◽  
pp. 877-882 ◽  
Author(s):  
Gloria A. Bachmann ◽  
Matthias Schaefers ◽  
Alkaz Uddin ◽  
Wulf H. Utian
Keyword(s):  
Postmenopausal Women ◽  
Estrogen Therapy ◽  
Transdermal Estrogen

scholarly journals PIH2 Topical Estrogen Therapy in Postmenopausal Women - Indian Experience

2012 ◽  
Vol 15 (7) ◽  
pp. A638
Author(s):  
S. Donde ◽  
G. Uchit ◽  
N. Valanju
Keyword(s):  
Postmenopausal Women ◽  
Estrogen Therapy ◽  
Indian Experience ◽  
Topical Estrogen

Efficacy of Citalopram as a Monotherapy or as an Adjunctive Treatment to Estrogen Therapy for Perimenopausal and Postmenopausal Women With Depression and Vasomotor Symptoms

2003 ◽  
Vol 64 (4) ◽  
pp. 473-479 ◽  
Author(s):  
Claudio N. Soares ◽  
Jennifer R. Poitras ◽  
Jennifer Prouty ◽  
Allison B. Alexander ◽  
Jan L. Shifren ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Estrogen Therapy ◽  
Adjunctive Treatment ◽  
Vasomotor Symptoms

Efficacy and safety of conjugated estrogen with bazedoxifene in postmenopausal women

Maturitas ◽  
2019 ◽  
Vol 124 ◽  
pp. 158
Author(s):  
Hee Dong Chae ◽  
Do-Young Kim ◽  
Hyun-Jin Kim ◽  
Sung-Hoon Kim ◽  
Byung-Moon Kang
Keyword(s):  
Postmenopausal Women ◽  
Efficacy And Safety ◽  
Conjugated Estrogen

scholarly journals Associations among Oral Estrogen Use, Free Testosterone Concentration, and Lean Body Mass among Postmenopausal Women1

2000 ◽  
Vol 85 (12) ◽  
pp. 4476-4480
Author(s):  
Barbara A. Gower ◽  
Lara Nyman
Keyword(s):  
Postmenopausal Women ◽  
Lean Body Mass ◽  
Body Mass ◽  
Lean Mass ◽  
Estrogen Therapy ◽  
Free Testosterone ◽  
Sex Hormone Binding Globulin ◽  
Serum Concentrations ◽  
Oral Estrogen ◽  
Regional Body Composition

Circulating concentrations of sex hormone-binding globulin (SHBG) are increased by use of oral estrogen. The objective of this study was to determine whether postmenopausal women who used oral estrogen had higher serum concentrations of SHBG and lower serum concentrations of free testosterone (T) than nonusers, and whether free T was associated with lean body mass, particularly skeletal muscle mass. Subjects were 70 postmenopausal women, 46–55 yr old, 46 of whom used oral estrogen. Total and regional body composition were determined by dual-energy x-ray absorptiometry. Serum concentrations of SHBG, total T, and estradiol (E2) were determined by RIA. Free T was calculated from concentrations of total T and SHBG. Hormone users had higher serum concentrations of E2 and SHBG (182.0 ± 58.5 vs. 82.9 ± 41.1 nmol/L, mean ± sd, P < 0.001) and lower concentrations of free T (3.7 ± 2.2 vs. 7.9± 4.1 pmol/L, mean ± sd, P < 0.001); total T did not differ. Total lean mass and leg lean mass were significantly correlated with free, but not total T [r values of 0.29 (P < 0.05) and 0.31 (P < 0.01) for total and leg lean mass, respectively, vs. free T]; arm lean mass was not correlated with either measure of T. Serum E2 was significantly correlated with SHBG (r = 0.50, P < 0.001) and free T (r = −0.33, P < 0.01). These observations imply that, by reducing the concentration of bioavailable T, oral estrogen therapy may accelerate or augment lean mass loss among postmenopausal women. This conclusion awaits confirmation by longitudinal observation.

Prolonged estrogen therapy in postmenopausal women

1960 ◽  
Vol 79 (5) ◽  
pp. 1035
Author(s):  
John J. Dettling
Keyword(s):  
Postmenopausal Women ◽  
Estrogen Therapy
Sign in / Sign up

Export Citation Format

Share Document